Skip to main content

Summary

at San Francisco, California and other locations
study started
estimated completion:

Description

Summary

The purpose of the REVERSE Post Approval Study (PAS) is to confirm the benefit observed in the REVERSE and RAFT pivotal studies in "real-world" clinical practice.

Official Title

The REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) Post Approval Study

Details

The REVERSE PAS will estimate the 3-year survival probability of freedom from heart failure hospitalization and heart failure events in patients implanted with a Medtronic CRT-D device who meet the expanded indication criteria with a QRS duration ≤ 150 ms.

Keywords

Heart Failure

Eligibility

You can join if…

  • Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • Patient has or is intended to receive or be treated with a Medtronic CRT-D who meets the expanded CRT-D indication criteria with a QRS ≤ 150ms
  • Patient within 30 days of implant

You CAN'T join if...

  • Patient who is, or will be, inaccessible for follow-up
  • Patient with exclusion criteria required by local law
  • Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Locations

  • San Francisco, California, 94143, United States
  • Redwood City, California, 94062, United States
  • Stanford, California, 94305, United States
  • Salinas, California, 93901, United States
  • Monterey, California, 93940, United States
  • Bakersfield, California, 93301, United States
  • Van Nuys, California, 91405, United States
  • Redding, California, 96001, United States
  • Los Angeles, California, 90048, United States
  • Downey, California, 90241, United States
  • Torrance, California, 90503, United States
  • Las Vegas, Nevada, 89169, United States
  • Henderson, Nevada, 89052, United States
  • Rancho Mirage, California, 92270, United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Medtronic
ID
NCT01660035
Study Type
Observational
Last Updated
October 4, 2017
I’m interested in this study!